Skip to content

XOMA Corporation XOMA Deferred Tax Assets

Deferred Tax Assets at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$22.61M-23.0%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$72.83M+492%
Zymeworks logo
ZymeworksZYME
$3.83M-20.5%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$30M-0.2%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$161M-96.0%
AbbVie logo
AbbVieABBV
$137M-94.7%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's deferred tax assets?
XOMA Corporation (XOMA) reported deferred tax assets of $103K in Q1 2026.
What does deferred tax assets mean?
Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.